---
title: Cannabis-Related Securities | Weekly Update | December 2 - 8, 2024
description: Cannabis-Related Securities Update
image: https://www.crbmonitor.com/hubfs/cannabis-financial-banking-bill.jpg
---

[![CRB Monitor](https://www.crbmonitor.com/hubfs/Crbmonitor%20-%20December2019/Images/logo.svg "CRB Monitor")](https://www.crbmonitor.com/)

Close

## Request More Info

We'd love to hear from you! Let us know how we can help.

# RESOURCES | Data Updates | Securities

Cannabis-Related Securities | Weekly Update | December 2 - 8, 2024

##### Published on December 12, 2024

**CRB Monitor Securities Database Updates **

During the week of December 2 - 8, 2024, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.

**Summary of the updates for the Week of December 2 - 8, 2024**:

| **Tier** | **Total #** | **Active / Inactive / Pre-IPO** | **Added** | **Removed** | **Net Change** |
| --- | --- | --- | --- | --- | --- |
| **Tier 1A** | **146** | **121 / 23 / 2** | **+0** | **-0** | **+0** |
| **Tier 1B** | **703** | **552 / 149 / 2** | **+0** | **-0** | **+0** |
| **Tier 2** | **301** | **282 / 14 / 5** | **+0** | **-1** | **-1** |
| **Tier 3** | **465** | **437 / 27 / 1** | **+1** | **-0** | **+1** |
| **Total Issuances** | **1,615** | **1,392 / 213 / 10** | **+1** | **-1** | **+0** |
| **Total Issuers   (w/o Pre-IPOs)** | **1,209** | **-** | **+1** | **-1** | **+0** |
| **Total Issuers    ****(w/ Pre-IPOs)** | **1,219** | **-** | **+1** | **-1** | **+0** |

 

**Removed 1 Tier 2 Security:**

- -1 =  Discarded Business Record: ("Phoenix Life Sciences International Limited") 
    - Rationale = Phoenix Life Sciences International Limited, based in Australia, is an adaptive healthcare solutions company. The company is primarily focused on diabetes management solutions. The company was previously involved in the cannabis industry through the research and development of various cannabinoid-based pharmaceutical products. However, the company's security has been revoked/delisted and it no longer trades (previously traded on OTC only). As a result, the company is now private. This is a business without any connection to (1) a cannabis license/"plant-touching" operation, (2) a Tier 1 CRB, and/or (3) a publicly-traded CRB. Therefore, this business no longer qualifies for inclusion.

**Added 1 Tier 3 Security:**

- +1 = New CRB: ("Institute of Biomedical Research Corp.")

All **newly-identified CRBs during the week**:

| **Company Name** | **Tier** | **Pure-Play** | **Sector** | **Description** |
| --- | --- | --- | --- | --- |
| [Institute of Biomedical Research Corp.](https://mrescorp.com/) | 3 | No | CBD - Pharma & Biotech | Institute of Biomedical Research Corp. ([OTC Pink: MRES](https://www.otcmarkets.com/stock/MRES/overview)), operating as [M2Bio Sciences](https://m2bio.co/), is a biotechnology company focused on alternative plant-based food, medicine and mental health therapeutic research. The company is involved in the cannabis industry through the research and development of cannabinoid (primarily cannabidiol) therapeutics. This mainly includes topical products, particularly for pets suffering from skin conditions. The company’s involvement with cannabinoids is only one of its areas of focus. This does not constitute a substantial revenue source, relative to its overall business. |

 

### Most Popular

### Subscribe For Updates

## Explore how CRBMonitor can simplify your cannabis-related compliance challenges.

Request Demo

### CRB Monitor Cannabis Corporate Intelligence

### Contact Us

[Info@CRBMonitor.com](mailto:Info@CRBMonitor.com)   
[844-672-3282](tel:844-672-3282)

###### [EVENTS & ENGAGEMENTS](https://www.crbmonitor.com/events-and-speaking-engagements) [CRB RISK TIERS](https://www.crbmonitor.com/resources/defining-cannabis-marijuana-related-business) [DIGITAL ASSETS](https://www.crbmonitor.com/digital-asset-related-businesses-and-securities)

###### [PRIVACY POLICY](https://www.crbmonitor.com/privacy-policy/)

### Pressroom

- [LinkedIn ](https://www.linkedin.com/company/mrb-monitor)

< !-- Google Tag Manager (noscript) -->

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Jim Francis",
    "url" : "https://www.crbmonitor.com/resources/author/jim-francis"
  },
  "dateModified" : "2024-12-12T18:29:06.061Z",
  "datePublished" : "2024-12-12T17:55:33.000Z",
  "headline" : "Cannabis-Related Securities | Weekly Update | December 2 - 8, 2024",
  "image" : [ "https://www.crbmonitor.com/hubfs/cannabis-financial-banking-bill.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://www.crbmonitor.com/resources/cannabis-related-securities-weekly-update-december-2-8-2024",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.crbmonitor.com/hubfs/logo_color_full.png"
    },
    "name" : "CRB Monitor"
  }
}
```